Abstract
According to WHO, up to 35% of the world's population suffers from allergic diseases, and this number is growing exponentially. Histamine has been proven to play a key physiological role in the pathogenesis of allergic disorders by affecting tissues through the activation of H1-receptors. H1-antagonists (antihistamines) are widely used to treat allergic disorders, being one of the most prescribed classes of drugs. The development of medications with high specific activity and low incidence of unwanted side effects is the main goal of pharmaceutical research, so antihistamines have evolved significantly since their first generation was introduced more than 50 years ago. This review analyzes aspects of classification and concepts of clinical use of antihistamines considering their individual specificity.
Key words: hypersensivity, histamine, histamine antagonists, allergic rhinitis, bronchial asthma, urticarial.
Key words: hypersensivity, histamine, histamine antagonists, allergic rhinitis, bronchial asthma, urticarial.
For citation:Guschin I.S., Kurbacheva O.M., Osipova P.S. Antihistamines in the treatment of allergic diseases: not as simple as it seems! Clinical review for general practice. 2023; 4 (8): 6–12 (In Russ.). DOI: 10.47407/kr2023.4.8.00325
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.